Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009:3:49-55.
Epub 2009 Jun 2.

Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland

Samir Aziz  1 , Alex Taylor, Andrzej McConnachie, Alex Kacperek, Ewan Kemp
Affiliations

Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland

Samir Aziz et al. Clin Ophthalmol. 2009.

Abstract

Aim: To evaluate proton-beam radiotherapy (PBRT) in the management of uveal melanoma in Scotland.

Methods: A retrospective review was undertaken on all patients receiving PBRT for uveal melanoma (1994-2005). Data obtained included: gender, past ocular/medical history, age, presenting complaint(s), diagnosis, laterality, tumor location/ultrasound characteristics, visual acuity (VA) and intraocular pressure. At post-treatment reviews (3, 6, 12, and 24 months), the following data was obtained: VA, intraocular pressure, tumor appearance and ultrasound characteristics. Mean follow up was 38.8 months.

Results: Seventy-six patients were included. Mean age was 64 years; male to female ratio was 1.1:1. Ninety-seven percent demonstrated initial treatment response; 87% had successful control of tumor growth. Mean pre-treatment tumor height was 6.2 mm v.s. 4.8 mm post-irradiation (p < 0.001). Pre-irradiation VA was <3/60 in 18.5% compared with 74% post-irradiation (p < 0.0001). There was a statistically significant association between adverse events (enucleation, metastasis) and greater maximal basal tumor diameter. Eighteen eyes were enucleated. The median survival time was estimated to be 54 months.

Conclusion: In our experience, PBRT is a precise, reliable and effective treatment in the management of large, and previously treated uveal melanomas. It prevents enucleation in the majority at short term follow-up.

Keywords: enucleation; proton-beam radiotherapy; tumor; uveal melanoma; visual acuity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier estimated cumulative adverse event rate (enucleation or distant metastasis) compared with follow-up time after proton beam irradiation.
See this image and copyright information in PMC

References

    1. Chiquet C, Grange JD, Ayzac L, et al. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas. Br J Ophthalmol. 2000;84:98–102. - PMC - PubMed
    1. Gragoudas ES, Lane AM, Regan S, et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000;118:773–8. - PubMed
    1. Wright PK, Damato BE. Auditing outcomes after treatment of Scottish patients with uveal melanoma in Liverpool. J R Coll Surg Edinb. 1999;44:260–4. - PubMed
    1. Mindel J, Finger P. Radiation therapy for choroidal melanoma. Therapeutic review. Surv Ophthamol. 1997;42:215–32. - PubMed
    1. Melia BM, Abramson DH, Albert DM, et al. Collaborative Ocular Melanoma Study Group. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16. Ophthalmology. 2001;108:348–66. - PubMed